Article info

PDF

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Authors

  1. Correspondence to M C van der Goes, Department of Rheumatology & Clinical Immunology (F02.127), University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands; m.c.vandergoes{at}umcutrecht.nl
View Full Text

Citation

Duru N, van der Goes MC, Jacobs JWG, et al
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Publication history

  • Received January 8, 2013
  • Revised June 2, 2013
  • Accepted June 26, 2013
  • First published July 19, 2013.
Online issue publication 
November 04, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.